HOME >> BIOLOGY >> NEWS
New studies on bone marrow failure diseases presented at scientific symposium Oct. 18-19

The latest advances in aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH) and other bone marrow failure diseases will be presented at the Bone Marrow Failure Scientific Symposium Oct. 18-19 in Washington, DC. This is the first international meeting covering all bone marrow diseases--life-threatening conditions for which, in most cases, the cause is unknown.

New research on stem cell transplantation, immunosuppressive treatments, drug therapies and alternative approaches will be presented by the world's leading physicians on bone marrow failure diseases.

The symposium is sponsored by the National Institutes of Health, including the Office of Rare Diseases, the National Heart, Lung and Blood Institute and the National Cancer Institute; and organized by Aplastic Anemia & MDS International Foundation, Inc. (AA&MDSIF). Co-chairs are Jaroslaw Maciejewski, MD, PhD, Cleveland Clinic Foundation, Taussig Cancer Center and Neal S. Young, MD, National Heart, Lung and Blood Institute.

More information on the symposium is at AA&MDSIF's web site: http://www.aamds.org

What:
Bone Marrow Failure Scientific Symposium

Who:
--National Heart, Lung and Blood Institute
--National Cancer Institute
--Office of Rare Diseases
--Aplastic Anemia & MDS International Foundation, Inc.

When:
Oct. 18-19, 2005

Where:
L'Enfant Plaza Hotel, 480 L'Enfant Plaza, Washington, DC
Press must register for the symposium. Accredited journalists receive complimentary registration.
To register contact: Brian Ruberry, 301-948-1709, br@allhealthpr.com.


'"/>

Contact: Brian Ruberry
br@allhealthpr.com
301-948-1709
Aplastic Anemia & MDS International Foundation
30-Sep-2005


Page: 1

Related biology news :

1. New studies on goats milk show it is more beneficial to health than cows milk
2. Berkeley Lab Life Sciences division awarded NIH grants for fruit fly, nematode studies
3. Obtaining valid consent for doing large genetic studies in developing countries
4. Short-term studies suggest that whole grain oats may reduce risk factors for coronary heart disease
5. New studies link the environment to Parkinsons disease
6. Ewwwww! UCLA anthropologist studies evolutions disgusting side
7. Genetic studies endow mice with new color vision
8. Epigenetic studies will provide a better understanding of disease
9. New mathematical model to add rigor to studies of disease genetics and evolution
10. Genes and groups of genes commonly shared between species, studies show
11. New bird, bat species revealed by extensive DNA barcode studies

Post Your Comments:
(Date:6/15/2015)... , June 16, 2015 ... Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies ... Forecast to 2020" published by MarketsandMarkets, The Natural Language ... at a CAGR of 18.4% for the forecast period ... and   46 F igures spread   through ...
(Date:6/10/2015)... 2015 According to a ... Technology (Ultrasound, TOF, Structured Light, Stereo Vision), Type(Image, ... and by Geography - Trends & Forecast to ... is expected to reach $3,319.71 Million by 2020, ... and 2020. Browse 71 market data ...
(Date:6/5/2015)... 5, 2015  Intrexon Corporation ("Intrexon") (NYSE: XON ... it has determined the final distribution ratio relating to ... shares of ZIOPHARM Oncology, Inc. ("ZIOPHARM") (NASDAQ: ZIOP ... the distribution date, as a pro rata dividend on ... purchase shares of Intrexon common stock ("Warrants"), outstanding on ...
Breaking Biology News(10 mins):Natural Language Processing Market Worth $13.4 Billion by 2020 2Natural Language Processing Market Worth $13.4 Billion by 2020 3Natural Language Processing Market Worth $13.4 Billion by 2020 4Natural Language Processing Market Worth $13.4 Billion by 2020 53D Sensor Market Worth $3,319.71 Million by 2020 23D Sensor Market Worth $3,319.71 Million by 2020 33D Sensor Market Worth $3,319.71 Million by 2020 4Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 2Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 3Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 4
(Date:6/29/2015)... ... 2015 , ... The global microfluidics market is expected to ... to 2020). The market is mainly driven by the rising geriatric population, growing ... lack of adequate healthcare and research infrastructure in emerging markets, dearth of skilled ...
(Date:6/29/2015)... 2015  Neuralstem, Inc. (NYSE MKT: CUR), a biopharmaceutical ... molecule and cell therapy treatments for central nervous system ... listing on the NASDAQ Capital Market under the symbol ... on the NYSE MKT until the market close on ... is expected to commence on July 13, 2015. ...
(Date:6/29/2015)... , June 29, 2015   For the seventh year ... to assess their overall digital maturity called the ... these companies are not maturing fast enough. While it,s ... in numerous ways overall and customers are increasingly "digital ... of digital customer engagement.  ...
(Date:6/26/2015)... VANCOUVER , June 26, 2015 /PRNewswire/ - iCo ... ICOTF), today announced that all nominees listed in ... as directors at its 2015 Annual Meeting of ... a vote by ballot, the following 5 nominees ... iCo Therapeutics to serve until the Company,s next ...
Breaking Biology Technology:Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 4Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 5Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 2Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 3Results from Digital Maturity Study Show Pharma Lagging 2Results from Digital Maturity Study Show Pharma Lagging 3Results from Digital Maturity Study Show Pharma Lagging 4iCo Therapeutics Announces Voting & Election Results from Annual Meeting of Shareholders 2iCo Therapeutics Announces Voting & Election Results from Annual Meeting of Shareholders 3
Cached News: